[1] KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society(ERS)[J]. Eur Heart J, 2020, 41(4): 543-603.
[2] BUI P V, MOUALLA M, UPSON D J. A possible association of diindolylmethane with pulmonary embolism and deep venous thrombosis[J]. Case Rep Med, 2016, 2016:7527098.
[3] 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J].中华医学杂志,2018,98(14):1060-1087.
[4] SHULMAN M, JENNIFER NJOKU I, MANU P. Thrombotic complications of treatment with antipsychotic drugs[J]. Minerva Med, 2013, 104(2): 175-184.
[5] WU C S, CHANG C M, CHEN C Y, et al. Association between antidepressants and venous thromboembolism in Taiwan[J]. J Clin Psychopharmacol, 2013, 33(1):31-37.
[6] BARBUI C, CONTI V, CIPRIANI A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies [J]. Drug Saf, 2014, 37(2): 79-90.
[7] ARASTEH O, NOMANI H, BAHARARA H, et al. Antipsychotic drugs and risk of developing venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis[J]. Curr Vasc Pharmacol, 2020, 18(6):632-643.
[8] ZHANG S, ZHAI Z, YANG Y, et al. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism:findings from a long-term follow-up study[J]. Int J cardiol, 2016, 202: 275-281.
[9] HEIT J A. Predicting the risk of venous thromboembolism recurrence [J]. Am J Hematol, 2012, 87(Suppl 1): S63-S67.
[10] HEIT J A, LAHR B D, PETTERSON T M, et al. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study [J]. Blood, 2011, 118(18): 4992-4999.
[11] REZZADEH K, BEHERY O A, KESTER B S, et al. Patellofemoral arthroplasty: short-term complications and risk factors[J]. J Knee Surg, 2020, 33(9): 912-918.
[12] WALLASCHOFSKI H, EIGENTHALER M,KIEFER M, et al. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism:pilot study[J]. J Clin Psychopharmacol, 2003, 23(5): 479-483.
[13] KOHN M A, KLOK F A, VAN ES N. D-dimer interval likelihood ratios for pulmonary embolism[J]. Acad Emerg Med, 2017, 24(7): 832-827.
[14] CUKER A, AREPALLY G M, CHONG B H, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism[J]. Blood Adv, 2018, 2(22):3360-3392.
[15] HARRINGA J B, BRACKEN R L, NAGLE S K, et al. Negative D-dimer testing excludes pulmonary embolism in non-high risk patients in the emergency department[J]. Emerg Radiol, 2017, 24(3):273-280. |
